Medical application use and the need for further research and assessment for clinical practice: Creation and integration of standards for best practice to alleviate poor application design

JAMA Dermatology

Volumn 149, Issue 6, 2013, Pages 661-662

  Misra, Satish ^a   Lewis, Thomas Lorchan ^b   Dy Aungst, Timothy ^c  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c Massachusetts College of Pharmacy   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACNE; CANCER RISK; CLINICAL PRACTICE; HEALTH CARE; HEALTH EDUCATION; HUMAN; INTEGRATED HEALTH CARE SYSTEM; INTERNET; MEDICAL RESEARCH; MEDICAL TECHNOLOGY; MELANOMA; MOBILE PHONE; NOTE; PHOTOTHERAPY; PREVALENCE; PRIORITY JOURNAL; SAFETY; SENSITIVITY AND SPECIFICITY; SKIN DEFECT; SKIN EXAMINATION; SMOKING CESSATION; TELEDERMATOLOGY;

CELLULAR PHONE; COMPUTERS, HANDHELD; DELIVERY OF HEALTH CARE; HUMANS; INFORMATION DISSEMINATION; MEDICAL INFORMATICS APPLICATIONS;

EID: 84879404769     PISSN: 21686068     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamadermatol.2013.606     Document Type: Note

References (7)

1. Wolf JA, Moreau J, Akilov O, et al. Diagnostic inaccuracy of smartphone applications for melanoma detection. JAMA Dermatol. 2013;149(4): 422-426.
2. USFoodandDrugAdministration.FDASafety and Innovation Act, updated July 31, 2012. http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/ Overview/ucm310927.htm Accessed January 23, 2012.
3. Abroms LC, Padmanabhan N, Thaweethai L, Phillips T. iPhone apps for smoking cessation: a content analysis. Am J Prev Med. 2011;40(3):279- 285.
4. Federal Trade Commission. "Acne cure" mobile app marketers will drop baseless claims under FTC settlements. Released September 8, 2011. http://www.ftc.gov/opa/2011/09/acnecure.shtm. Accessed February 3, 2013.
5. Viola KV, Tolpinrud WL, Gross CP, Kirsner RS, Imaeda S, Federman DG. Outcomes of referral to dermatology for suspicious lesions: implications for teledermatology. Arch Dermatol. 2011;147 (5):556-560.
6. Shurtz S, Foster MJ. Developing and using a rubric for evaluating evidence-based medicine pointof- care tools. J Med Libr Assoc. 2011;99(3):247- 254.
7. Quinn CC, Shardell MD, Terrin ML, Barr EA, Ballew SH, Gruber-Baldini AL. Cluster-randomized trial of a mobile phone personalized behavioral intervention for blood glucose control. Diabetes Care. 2011; 34(9):1934-1942.